Unfortunately not.
The company chose not to release the slide with remestemcel only in under 65's. From what they did release you can figure out that it did not show any mortality benefit- which is y it wasn't released.
I believe 11 out of 28 did not make it. In the under 65's taking reme and no dex. Its ironic that they said dex made no difference in mortality.... well neither did reme...
Growing Confidence on COVID-19 Application, page-30
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |